Cardioversion

Yan Liu, MD, PhD, is a board-certified, experienced cardiologist and cardio-oncologist at Ascension Texas in Austin and Burnet, Texas. Dr. Liu has expertise in treating chemotherapy induced cardiotoxicity, radiation heart disease, cardiovascular disease in cancer patients and survivors, immunotherapy induced heart disease, coronary artery and vascular disease, arrhythmias, heart failure, heart valve disease, and more. With our multidisciplinary approach, Dr. Liu works with a team of cancer specialists to deliver comprehensive, compassionate care for cancer patients at any stage of their treatment journey to help them achieve the best life quality and overall outcome.

Dr. Liu is the Director of Ascension Texas Cardio-Oncology service line. He specializes in cardio-oncology, general cardiology, cardiovascular imaging, and vascular medicine. Additionally, Dr. Liu is an associate professor of medicine in the Dell Medical School at the University of Texas at Austin.

Dr. Liu completed his cardiology training and served as the chief cardiology fellow and assistant professor at the University of North Carolina at Chapel Hill Hospitals prior to joining Ascension.

Dr. Liu’s research is focused on the novel molecular pathways in cardiovascular disease and cancer, leading to innovative therapy and drug development in cardiovascular disease and cardio-oncology. He served as the principal investigator in several investigator-initiated original clinical studies funded by national non-profit agencies.

Dr. Liu has authored more than 40 peer-reviewed scientific papers and is an inventor on several patents that lead to two clinical-stage biotech companies and an FDA-approved, guideline-recommended first-in-class chemoprotection drug. His research established p16INK4a as the key molecular mechanism linking cancer and heart disease, setting the molecular foundation for cardio-oncology as a novel clinical specialty. Dr. Liu's most recent innovation involves a novel cardio-oncology service line care model in improving cardio-oncology care quality, access and health equity.

Dr. Liu served on many committees and boards in clinical care guidance, including editor/editorial board of Cardio-Oncology Journal, Journal of Cardio-Oncology, the cardio-oncology advisory board at Pfizer and the expert panel at Texas Medical Board. He is also the past president of Texas Medical Association Burnet-Lampasas County Medical Society.

Dr. Liu’s research and innovation have been featured by many major international/national media, including BBC World News, ScienceDaily, Yahoo! News and WebMD. His most recent awards includes Ascension Seton Foundation Care Champion.